Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to ...

Welcome to the Evolent earnings conference call for the fourth quarter and year ended December 31, 2024. All participants ...

Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...

Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but ...

Evolent Health, Inc. ( NYSE: EVH) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - ...

Discover key insights from Evolent Health's Q4 2024 earnings call, focusing on 30% revenue growth, contract renegotiations, projections for 2025, ...

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of ...

For the current quarter ending in March, Evolent Health said it expects revenue in the range of $440 million to $470 million. The company expects full-year revenue in the range of $2.06 billion to ...

NYSE EVH opened at $10.44 on Friday. Evolent Health has a one year low of $9.45 and a one year high of $35.00. The stock has a 50-day moving average of $10.75 and a 200 day moving average of $18. ...

Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth ...

Full Year 2024 Results Key Financial Results Revenue: US$2.55b (up 30% from FY 2023).

Shares of NYSE EVH opened at $10.44 on Friday. Evolent Health has a 1-year low of $9.45 and a 1-year high of $35.00. The company has a 50-day moving average of $10.75 and a two-hundred day moving ...